Healthcare

Monitoring Medical Cannabis

Jan 26, 2018

Giuseppe Cannazza and Cinzia Citti from the University of Modena and Reggio Emilia discuss the growing interest in the use of medicinal cannabis in Europe and the analytical challenges involved.

AXIM Begins Clinical Trials with CBG Ointment

May 16, 2016

AXIM Biotechnologies, a Netherlands-based biotechnology company, announced that it would be entering clinical trials with its patent-pending cannabigerol (CBG) topical ointment formulation AX-1602, the company said in a May 16, 2016 press statement to BioPharm Inter

Pages

  • Twitter
  • Facebook
  • Linkedin
  • Rss